
|Videos|June 17, 2021
Multiple Sclerosis Care During a Pandemic
Join Ahmed Obeidat, MD, PhD; Anne Cross, MD; and Gloria von Geldern, MD, for the third program in this series, where they offer insight from neurology specialists on applying lessons learned from the COVID-19 pandemic into clinical practice when managing patients with multiple sclerosis.
Advertisement
————————————
Panelists
- Ahmed Obeidat, MD, PhD
Assistant Professor, Department of Neurology, Neuroimmunology and Multiple Sclerosis; Director, Neuroimmunology and MS Fellowship Program, The Medical College of Wisconsin - Anne Cross, MD
Professor of Neurology; Section Head, Neuroimmunology/Multiple Sclerosis, Washington University School of Medicine - Gloria von Geldern, MD
Associate Professor of Neurology, University of Washington
Key Learning Objectives
- Adapting to virtual MS visits during COVID-19 including pros and cons
- Continuation of MS multidisciplinary care during COVID-19
- Impact of COVID-19 on MS research
- COVID-19 vaccine considerations in patients with MS
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Long-Term Efficacy of Anti-CD20 Therapies in MS: What the Evidence Shows
2
Managing Infection Risk and Safety Monitoring with Anti-CD20 MS Disease Modifying Therapy
3
Former NFL Running Back Chris Johnson Diagnosed With ALS at 40
4
FDA Clears PoNS Device for Stroke Rehabilitation, Expanding Neurostimulation Beyond MS Indication
5


















